Page last updated: 2024-09-05

sk&f 107260 and echistatin

sk&f 107260 has been researched along with echistatin in 1 studies

Compound Research Comparison

Studies
(sk&f 107260)
Trials
(sk&f 107260)
Recent Studies (post-2010)
(sk&f 107260)
Studies
(echistatin)
Trials
(echistatin)
Recent Studies (post-2010) (echistatin)
1100184022

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, FE; Bennett, D; Bondinell, W; Chen, W; Heys, JR; Hwang, SM; Johanson, K; Ku, TW; Landvatter, SW; Nichols, AJ; Powers, DA; Samanen, J; Stadel, JM; Wong, A1

Other Studies

1 other study(ies) available for sk&f 107260 and echistatin

ArticleYear
Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 285, Issue:1

    Topics: Binding, Competitive; Blood Platelets; Cations, Divalent; Dose-Response Relationship, Drug; Fibrinogen; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

1998